Oxygen Therapy in Chronic CO2 Retention
A 68-year-old man with a 40-year history of COPD is admitted with worsening breathlessness and a productive cough. On room air his respiratory rate is 26/min and SpO2 is 84%. Arterial blood gas on room air: pH 7.31, PaCO2 66 mmHg, HCO3- 31 mEq/L, PaO2 52 mmHg. The nurse applies nasal cannula oxygen at 6 L/min. Thirty minutes later SpO2 is 99%, the patient is drowsy and difficult to rouse, and his respiratory rate has fallen to 10/min. A repeat ABG shows pH 7.22, PaCO2 82 mmHg, HCO3- 31 mEq/L, PaO2 110 mmHg. The patient's baseline ABG from clinic two months ago showed pH 7.36, PaCO2 58 mmHg, HCO3- 32 mEq/L. He has no fever and no new chest pain. The nurse must decide whether the oxygen flow is helping or harming him.
1. Interpret the admission ABG and explain what it tells you about the chronicity of his CO2 retention.
Read the worked answer
The admission ABG shows a pH of 7.31 (acidemia), PaCO2 of 66 mmHg (hypercapnia), and HCO3- of 31 mEq/L (elevated). The primary abnormality is respiratory acidosis because CO2 is elevated and pH is low. The bicarbonate is elevated because the kidneys retain bicarbonate over days to weeks in chronic CO2 retention. The baseline clinic ABG, with pH 7.36, PaCO2 58, and HCO3- 32, shows that this patient already lives with chronic compensated respiratory acidosis. On admission the pH has fallen further and the PaCO2 has risen, so this is an acute exacerbation superimposed on chronic retention. The PaO2 of 52 mmHg confirms significant hypoxemia. The reasoning is that a normal bicarbonate in acute respiratory acidosis would be about 24 to 26 mEq/L; a value of 31 indicates renal compensation and therefore chronicity. The history of COPD supports this interpretation.
2. Explain the mechanism by which high-flow oxygen produced drowsiness and a rising PaCO2 in this patient.
Read the worked answer
In chronic CO2 retention, the central chemoreceptors in the medulla become less responsive to CO2 because bicarbonate buffering in the cerebrospinal fluid blunts the pH change. Ventilation then depends more on peripheral chemoreceptors in the carotid and aortic bodies, which respond to low PaO2. When the nurse gives 6 L/min and the PaO2 rises from 52 to 110 mmHg, the hypoxic stimulus to breathe is removed. The patient hypoventilates, his respiratory rate falls to 10/min, and PaCO2 rises from 66 to 82 mmHg. The resulting fall in pH to 7.22 produces the drowsiness. A second mechanism is the Haldane effect: oxygenated hemoglobin binds less CO2, so increased oxygenation can raise the CO2 carried in plasma. Worsening ventilation-perfusion mismatch can also contribute. The reasoning is not that oxygen is toxic to all COPD patients, but that excessive oxygen can remove the patient's main respiratory drive. The target is usually SpO2 88% to 92%, not 99%.
3. What should the nurse do next, and what monitoring prevents a repeat episode?
Read the worked answer
The nurse should immediately reduce the oxygen flow and titrate it to the ordered target, usually SpO2 88% to 92% for a patient with chronic CO2 retention. The nurse should stay with the patient, assess respiratory rate, depth, and level of consciousness, and call the provider because the patient is drowsy and the ABG is worsening. Continuous pulse oximetry and frequent vital signs are needed, along with repeat ABG per order. The nurse should avoid sedatives or opioids that further depress ventilation and should not simply increase oxygen because the saturation looks low. The reasoning is that the problem is hypoventilation from loss of the hypoxic drive plus possible V/Q mismatch, so the treatment is controlled oxygenation and support of ventilation. If the patient does not improve, noninvasive ventilation may be needed. Documenting the target saturation and the baseline ABG helps prevent the same error on the next shift.